Evidence map›Paper›PMID 41537308›Full record

ArticleBriefings in bioinformatics2026

CoxMDS: multiple data splitting for high-dimensional mediation analysis with survival outcomes in epigenome-wide studies.

Minhao Yao, Peixin Tian, Xihao Li, Shijia Bian, Gao Wang, Yian Gu, Ana Navas-Acien, Badri N Vardarajan, Daniel W Belsky, Gary W Miller and 2 more

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Minhao YaoCentre for Quantitative Medicine, Duke-NUS Medical School, National University of Singapore, 8 College Road, Singapore 169857, Singapore.
Peixin TianFirst Affiliated Hospital of Kunming Medical University, Kunming Medical University, 295 Xichang Road, Kunming, Yunnan Province 650032, China.
Xihao LiDepartment of Biostatistics, University of North Carolina at Chapel Hill, 135 Dauer Drive, Chapel Hill, NC 27599, United States.
Shijia BianDepartment of Biostatistics and Bioinformatics, Emory University, 1518 Clifton Road, Atlanta, GA 30322, United States.
Gao WangCenter for Statistical Genetics, Gertrude H. Sergievsky Center, Columbia University Medical Center, 630 West 168th Street, New York, NY 10032, United States.
Yian GuCenter for Statistical Genetics, Gertrude H. Sergievsky Center, Columbia University Medical Center, 630 West 168th Street, New York, NY 10032, United States.
Ana Navas-AcienDepartment of Environmental Health Sciences, Columbia University, 722 West 168th Street, New York, NY 10032, United States.
Badri N VardarajanDepartment of Neurology, Columbia University, 710 West 168th Street, New York, NY 10032, United States.
Daniel W BelskyDepartment of Epidemiology, Columbia University, 722 West 168th Street, New York, NY 10032, United States.
Gary W MillerDepartment of Environmental Health Sciences, Columbia University, 722 West 168th Street, New York, NY 10032, United States.
Andrea A BaccarelliOffice of the Dean, Harvard T.H. Chan School of Public Health, Harvard University, 677 Huntington Avenue, Boston, MA 02115, United States.
Zhonghua LiuDepartment of Biostatistics, Columbia University, 722 West 168th Street, New York, NY 10032, United States.

Funding

Robust Mendelian Randomization Framework with Multi-Omics Data for Alzheimer's Disease and Related DementiasR01AG086379 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Zhonghua Liu · 2024 to 2026
$1.6M
NIA NIH HHS R01 AG086379NIH HHS R01AG086379
6 · The paper itself

Abstract

Causal mediation analysis investigates whether the effect of an exposure on an outcome operates through intermediate variables known as mediators. Although progress has been made in high-dimensional mediation analysis, current methods do not reliably control the false discovery rate (FDR) in finite samples, especially when mediators are moderately to highly correlated or follow non-Gaussian distributions. These challenges frequently arise in DNA methylation studies. We introduce CoxMDS, a multiple data splitting method that uses Cox proportional hazards models to identify putative causal mediators for survival outcomes. CoxMDS ensures finite-sample FDR control even in the presence of correlated or non-Gaussian mediators. Through simulations, CoxMDS is shown to maintain FDR control and achieve higher statistical power compared with existing approaches. In applications to DNA methylation data with survival outcomes, CoxMDS identified eight CpG sites in The Cancer Genome Atlas that are consistent with the hypothesis that DNA methylation may mediate the effect of smoking on lung cancer survival, and two CpG sites in the Alzheimer's Disease Neuroimaging Initiative that are consistent with the hypothesis that DNA methylation may mediate the effect of smoking on time to Alzheimer's disease conversion.

Indexed as

DNA MethylationEpigenomeLung NeoplasmsMediation AnalysisAlzheimer DiseaseComputer SimulationCpG IslandsGenome-Wide Association StudyHumansProportional Hazards ModelsSmokingSurvival Analysiscausal mediation analysisdata splittingDNA methylationfalse discovery ratesurvival outcomes

Identifiers

PMID41537308
PMCPMC12805255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.